Chronic constipation is a common and often under-recognised condition, affecting individuals with both neurological and functional causes. Whether linked to spinal cord injury, multiple sclerosis, Parkinson’s disease, or idiopathic slow transit, constipation significantly impairs quality of life and places a considerable burden on patients and healthcare systems alike.
While many traditional interventions are available, few offer a sustainable long-term, non-pharmacological solution. MOWOOT II addresses this therapeutic gap with a medically certified, non-invasive device that supports natural bowel function without the use of drugs, supplements or invasive procedures.
MOWOOT II replicates the effects of abdominal massage therapy by applying gentle, rhythmic pressure along the colon pathway to stimulate peristalsis – an approach known as Intermittent Colonic Exoperistalsis. With just 10 to 20 minutes of daily use, patients report improved bowel regularity, reduced bloating, and decreased reliance on laxatives or enemas.
Fifteen scientific publications support MOWOOT’s clinical benefits, demonstrating a high positive responder rate and a strong adherence to treatment in patients with both neurogenic bowel dysfunction and functional constipation with no serious adverse events reported. These findings highlight MOWOOT’s role not only as a symptom reliever but as an effective tool for long-term bowel management.
Designed for ease of use in both clinical and home settings, the device is especially valuable for patients with limited mobility or who rely on carers. MOWOOT II can be used as a complement to or a substitute for other bowel care strategies, making it a new and versatile addition to the bowel management toolkit.
At the ACP 2025 conference in Milton Keynes in May 2025, the MOWOOT II was presented to UK’s healthcare professionals from across continence care, physiotherapy and specialist nursing. The response was overwhelmingly positive, with many clinicians recognising the need for practical, evidence-based tools that can be tailored to individual patient needs.
Because every patient is different, and successful bowel care requires a personalised approach, having a variety of tools available is essential. MOWOOT II empowers patients and clinicians alike in striving for and supporting better outcomes, improved comfort, and greater dignity in bowel care.
As healthcare in the UK and across the NHS increasingly shifts towards preventative and non-invasive solutions, MOWOOT II stands out as a gentle, effective, and patient-centered innovation that brings relief to those who need it most.
For more information on MOWOOT II, contact Win Health Medical Ltd:
P: 01835 864866 | E: [email protected] | W: www.win-health.com
